Deck Kelly 4
4 · Inhibrx Biosciences, Inc. · Filed Apr 2, 2025
Insider Transaction Report
Form 4
Deck Kelly
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2025-04-01+15,000→ 15,000 totalExercise: $14.05Exp: 2035-04-01→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the total shares subject to this stock option will become exercisable on April 1, 2026, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.